IBDEI221 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,32794,1,4,0)
 ;;=4^H40.51X3
 ;;^UTILITY(U,$J,358.3,32794,2)
 ;;=^5133507
 ;;^UTILITY(U,$J,358.3,32795,0)
 ;;=H40.51X4^^128^1670^36
 ;;^UTILITY(U,$J,358.3,32795,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32795,1,3,0)
 ;;=3^GLC 2nd to Oth Eye d/o,OD,Indeterminate Stage
 ;;^UTILITY(U,$J,358.3,32795,1,4,0)
 ;;=4^H40.51X4
 ;;^UTILITY(U,$J,358.3,32795,2)
 ;;=^5005891
 ;;^UTILITY(U,$J,358.3,32796,0)
 ;;=H40.63X0^^128^1670^57
 ;;^UTILITY(U,$J,358.3,32796,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32796,1,3,0)
 ;;=3^GLU 2nd to Drugs,OU,Stage Unspec
 ;;^UTILITY(U,$J,358.3,32796,1,4,0)
 ;;=4^H40.63X0
 ;;^UTILITY(U,$J,358.3,32796,2)
 ;;=^5005914
 ;;^UTILITY(U,$J,358.3,32797,0)
 ;;=H40.63X1^^128^1670^58
 ;;^UTILITY(U,$J,358.3,32797,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32797,1,3,0)
 ;;=3^GLU 2nd to Drugs,OU,MIld Stage
 ;;^UTILITY(U,$J,358.3,32797,1,4,0)
 ;;=4^H40.63X1
 ;;^UTILITY(U,$J,358.3,32797,2)
 ;;=^5005915
 ;;^UTILITY(U,$J,358.3,32798,0)
 ;;=H40.63X2^^128^1670^59
 ;;^UTILITY(U,$J,358.3,32798,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32798,1,3,0)
 ;;=3^GLU 2nd to Drugs,OU,Moderate Stage
 ;;^UTILITY(U,$J,358.3,32798,1,4,0)
 ;;=4^H40.63X2
 ;;^UTILITY(U,$J,358.3,32798,2)
 ;;=^5005916
 ;;^UTILITY(U,$J,358.3,32799,0)
 ;;=H40.63X3^^128^1670^60
 ;;^UTILITY(U,$J,358.3,32799,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32799,1,3,0)
 ;;=3^GLU 2nd to Drugs,OU,Severe Stage
 ;;^UTILITY(U,$J,358.3,32799,1,4,0)
 ;;=4^H40.63X3
 ;;^UTILITY(U,$J,358.3,32799,2)
 ;;=^5005917
 ;;^UTILITY(U,$J,358.3,32800,0)
 ;;=H40.63X4^^128^1670^61
 ;;^UTILITY(U,$J,358.3,32800,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32800,1,3,0)
 ;;=3^GLU 2nd to Drugs,OU,Indeterminate Stage
 ;;^UTILITY(U,$J,358.3,32800,1,4,0)
 ;;=4^H40.63X4
 ;;^UTILITY(U,$J,358.3,32800,2)
 ;;=^5005918
 ;;^UTILITY(U,$J,358.3,32801,0)
 ;;=H40.62X0^^128^1670^52
 ;;^UTILITY(U,$J,358.3,32801,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32801,1,3,0)
 ;;=3^GLU 2nd to Drugs,OS,Stage Unspec
 ;;^UTILITY(U,$J,358.3,32801,1,4,0)
 ;;=4^H40.62X0
 ;;^UTILITY(U,$J,358.3,32801,2)
 ;;=^5005910
 ;;^UTILITY(U,$J,358.3,32802,0)
 ;;=H40.62X1^^128^1670^53
 ;;^UTILITY(U,$J,358.3,32802,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32802,1,3,0)
 ;;=3^GLU 2nd to Drugs,OS,Mild Stage
 ;;^UTILITY(U,$J,358.3,32802,1,4,0)
 ;;=4^H40.62X1
 ;;^UTILITY(U,$J,358.3,32802,2)
 ;;=^5005911
 ;;^UTILITY(U,$J,358.3,32803,0)
 ;;=H40.62X2^^128^1670^54
 ;;^UTILITY(U,$J,358.3,32803,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32803,1,3,0)
 ;;=3^GLU 2nd to Drugs,OS,Moderate Stage
 ;;^UTILITY(U,$J,358.3,32803,1,4,0)
 ;;=4^H40.62X2
 ;;^UTILITY(U,$J,358.3,32803,2)
 ;;=^5005912
 ;;^UTILITY(U,$J,358.3,32804,0)
 ;;=H40.62X3^^128^1670^55
 ;;^UTILITY(U,$J,358.3,32804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32804,1,3,0)
 ;;=3^GLU 2nd to Drugs,OS,Severe Stage
 ;;^UTILITY(U,$J,358.3,32804,1,4,0)
 ;;=4^H40.62X3
 ;;^UTILITY(U,$J,358.3,32804,2)
 ;;=^5133510
 ;;^UTILITY(U,$J,358.3,32805,0)
 ;;=H40.62X4^^128^1670^56
 ;;^UTILITY(U,$J,358.3,32805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32805,1,3,0)
 ;;=3^GLU 2nd to Drugs,OS,Indeterminate Stage
 ;;^UTILITY(U,$J,358.3,32805,1,4,0)
 ;;=4^H40.62X4
 ;;^UTILITY(U,$J,358.3,32805,2)
 ;;=^5005913
 ;;^UTILITY(U,$J,358.3,32806,0)
 ;;=H40.61X0^^128^1670^47
 ;;^UTILITY(U,$J,358.3,32806,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32806,1,3,0)
 ;;=3^GLU 2nd to Drugs,OD,Stage Unspec
